An impressive database containing a network of 989 plasma proteins on 225 human diseases has been created by Dr Jie Zheng, Professor Tom Gaunt and many other researchers from the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol.
A potential cause of what makes the coronavirus highly infectious – namely, the ability of the virus to bind to a specific protein found on the surface of human cells - has been identified by a team of scientists led by the University of Bristol.
Bristol firm Condense Reality (CR) are working with BT Applied Research to create a hologram-style immersive streaming technology, allowing viewers to watch sporting events with AR in their living rooms.
A study led by the University of Bristol has revealed a new way of utilizing the drug Pembrolizumab to help in the fight against cancer. The research, published in Science Signaling, outlines how the antibody can aid the cancer-killing soldiers of the immune system, T-cells.
emPOWER aims to accomplish what up to date, has only been possible in science fiction. I was fortunate enough to interview Prof. Jonathan Rossiter, a professor of Robotics at the University of Bristol leading this project.
A new round of recruitment to the second phase of a clinical trial for the COVID-19 Oxford Vaccine (ChAdOx1 nCoV-19) has begun in Bristol. Jack Lennard and Evy Tang tell us about their experience being part of COVID-19 trials.